Healthcare Industry News: ultrasound
News Release - June 28, 2013
Toshiba Cardiac Ultrasound Improves Visualization, Diagnostic AccuracyNew Aplio 500 CV and 300 CV Showcased at ASE
MINNEAPOLIS--(Healthcare Sales & Marketing Network)--To improve exam efficiency and increase accuracy of cardiovascular disease diagnoses, Toshiba America Medical Systems, Inc. will showcase its AplioTM 500 CV, 300 CV and ArtidaTM ultrasound systems at this year’s American Society of Echocardiography (ASE) annual meeting in Minneapolis, June 29 – July 2, 2013 (Booth #415).
The Aplio 500 CV and 300 CV are premier systems for all 2D cardiovascular exams. The systems feature Toshiba’s 2D Wall Motion Tracking technology, providing exceptional visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility. Through the use of on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), Toshiba’s Aplio CV systems are designed to provide comprehensive information at the patient’s bedside.
The Aplio Artida is Toshiba’s flagship cardiovascular ultrasound system, offering 3D Wall Motion Tracking software, which provides accurate and reproducible quantitative analysis of cardiac function. The Artida’s enhanced single-beat 3D acquisition allows physicians to obtain high-quality 3D images on a wider range of patients, including those with arrhythmias and shortness of breath.
A Lunch & Learn Session will be hosted by three presenters discussing their experiences using Toshiba’s cardiovascular ultrasound systems:
Hans Joachim Nesser, M.D., Elisabethinen Teaching Hospital, Linz, Austria
John Gorcsan III, M.D., Pittsburgh, Pa.
Gul H. Dadlani, M.D., All Children's Hospital, St. Petersburg, Fla.
Presentations will be on Saturday, June 29, at 11:45 a.m. CDT in room #101.
“Toshiba’s cardiovascular ultrasound systems provide the industry’s highest-resolution images with the ability to deliver crucial clinical data in real time,” said Tomohiro Hasegawa, director, ultrasound Business Unit, Toshiba. “Combining the Aplio Artida with the Aplio 500 and 300 gives Toshiba a complete cardiovascular ultrasound portfolio for virtually any imaging need.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 210,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$ 61.7 billion). Visit Toshiba’s website at www.toshiba.co.jp/index.htm.
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.